Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-072529
Filing Date
2022-06-17
Accepted
2022-06-17 21:33:36
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2218834-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2218834-3_4seq1.xml 4 3470
  Complete submission text file 0001104659-22-072529.txt   4837
Mailing Address C/O NYSE EURONEXT 11 WALL STREET NEW YORK NY 10005
Business Address
LEIBOWITZ LAWRENCE E (Reporting) CIK: 0001276505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40949 | Film No.: 221025784

Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software